Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma is one of the deadliest malignancies in humans. Despite advances in systemic therapy, prognosis still remains poor. However, recent discoveries in the main biological event in pancreatic carcinogenesis, the KRAS mutation, have broadened our understand...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jesus, Victor Hugo Fonseca, Mathias-Machado, Maria Cecília, de Farias, João Paulo Fogacci, Aruquipa, Marcelo Porfirio Sunagua, Jácome, Alexandre A., Peixoto, Renata D’Alpino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605759/
https://www.ncbi.nlm.nih.gov/pubmed/37894382
http://dx.doi.org/10.3390/cancers15205015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605759/
https://www.ncbi.nlm.nih.gov/pubmed/37894382
http://dx.doi.org/10.3390/cancers15205015

Ejemplares similares